Top Tech Companies (251)
Don't see your company?
Create a company profile
We are a biotech company developing microbiome-based female health products. Our patented bioactive intimate serum helps to fight bad bacteria for improved urinary tract and intimate health.
At AviadoBio our mission is to potentially transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies for diseases including frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The Company’s technology is based on pioneering research from King’s College London and the UK Dementia Research Institute.
We are making surgery safer, smarter, and greener - using the power of AI and sensor intelligence.
SERG Technologies is a digital health and care solutions provider for people living with neurodegenerative movement disorders.
We are building the sex, love and intimacy superbrand of the future. Kama is a wellbeing platform based on the science-backed idea that pleasure is health. With stress being the number one proxy killer in the world today, our mental health is more important than ever. As a society, however, we too often focus on pain and look to the brain to restore balance. This is why Kama has a different approach to wellbeing. We are shifting the focus to our body and placing pleasure at the forefront of the experience, regardless of your background, sexual preferences, body type, age, or gender. Our first product, live on the app store now, is a sexual wellness self-discovery guide for gentle exploration, real communication, and fulfilling intimacy. We offer a personal experience that is expertly curated and backed by science. More than a business, Kama is a social movement aimed at turning the biggest cultural taboo into a positive conversation by building a diverse and engaged community. Our investors are a diverse group of the world’s leading VC firms and influential angels, including AlleyCorp (led by Kevin Ryan, founder of MongoDB, Zola, Gilt Groupe, Business Insider), Female Founders Fund, and Raine Group.
Huma is a global digital health technology company that uses AI to advance digital-first care delivery and research to help people live longer, fuller lives. Huma's regulated Software as a Medical Device is the only disease agnostic platform to hold both EU MDR Class IIb and US FDA Class II regulatory status. It powers: - Digital first care for health systems - Companion apps to support patients through treatment and drug therapies - Virtual clinical trials to accelerate research
At Convatec, #ForeverCaring is our promise to patients & healthcare providers, as we deliver pioneering trusted medical solutions to improve the lives we touch.
Palta is a thriving family of Wellbeing and HealthTech brands. We partner with ambitious founders and exceptional talent to transform innovative ideas into life-changing apps that make a positive impact at a global scale. With over 700 employees on board, our offices stretch across the UK, US, EU and Israel
MedShr is a network and technology platform that enables doctors to share their knowledge and skills to improve healthcare and save lives. Join at www.medshr.it! @medshronline Developed by doctors, MedShr is the easiest & safest way for medical professionals to discover, discuss and share clinical cases and medical images. Join our community and connect with thousands of verified doctors, healthcare professionals and medical students sharing knowledge and learning from each other in a secure private network. MedShr has been featured on the BBC, Sky News, The Telegraph & The Evening Standard. “A revolution in the way Medical Knowledge spreads” ***** - Dr Tzalamouras Basilis, Interventional Cardiology Fellow “An excellent way of discussing cases” ***** - Dr Layla Thurston, Junior Doctor “This is amazing – like Instagram meets YouTube for doctors” ***** - Dr Antonio Colombo, Interventional Cardiologist “Really useful – a must-have for doctors” ***** - Mr Antony Perrera, Consultant Orthopaedic Surgeon “MedShr is a brilliant idea - smartphones connect doctors, making it possible for aid workers to get an instant medical diagnosis” ***** - Rohan Silver, Evening Standard DISCOVER AND DISCUSS MEDICAL IMAGES & CASES SHARE KNOWLEDGE WITH VERIFIED MEMBERS EXPAND YOUR PROFESSIONAL NETWORK HELP MAKE A DIFFERENCE For support, suggestions and feedback, please contact us at [email protected]
At Touchlight we are revolutionising DNA. Our Company and technology is built on the conviction that DNA is fundamental to the future of medicine. By moving away from today's restrictive biological approaches, we have made DNA simple. Our unique dbDNA™ (or "doggybone" DNA) vector is optimised for use in advanced genetic medicines, being safer and more efficacious than conventional plasmid DNA. The platform, based on enzymatic technology, enable DNA production at unprecedented scale, speed and purity. We are leveraging our platform to develop the next generation of DNA vaccines for oncology and infectious diseases, in house and in collaboration with industry partners and academics, as well as enabling manufacture of advanced therapies (viral vectors, mRNA vaccines, and cell therapies) through our CDMO, Touchlight DNA Services.
The WeWALK team is on a mission to enhance the mobility of visually impaired people with cutting-edge technology driven by their lived and professional experience of visual impairment. WeWALK's patented technology smart cane improves safety and independence with obstacle detection, accessible multimodal navigation, and public transport integration. WeWALK has already impacted lives in over 59 countries and has been recognised as a TIME Best Invention, Amazon's Startup of the Year, and an Edison Gold Award. WeWALK continuously expands its feature set through R&D collaborations with Microsoft, Imperial College London, the Royal National Institute of Blind People (RNIB), and other global visually impaired organization partners.
The next generation care enablement platform - with everything care teams need to resolve caseload quickly and safely
Clustermarket is the world-leading lab management system helping laboratories optimize their operations and accelerate results. Clustermarket equips research teams with an easy-to-use software solution enabling them to coordinate equipment usage, plan maintenance activities, and generate reports and forecasts for resource planning. The intuitive system is designed for fast implementation and high adoption within the organization, whilst also offering integrations with various other software solutions
Digistain ® - Leading digital transformation in cancer diagnostics - radically faster gold standard risk scoring analytics at a dramatically lower cost A Digital Solution To Cancer Grading And Prognosis approved by the UK’s Medicines & Healthcare products Regulatory Agency (MHRA), DIGISTAIN® is a patented risk profiling test for hormone receptor-positive breast cancer patients. Digistain’s easy-to-read report provides both physician and patient clear actionable information to help determine the best course of treatment and indeed whether cytotoxic therapy in addition to hormone therapy is required. The MHRA approved DIGISTAIN technology is based on 15 years of research and development pioneered by respected cancer research scientists at Imperial College with Professor Chris Phillips of the Biomedical Optics Division and Cancer Research UK (CRUK) with Professor Sir Nicholas Wright of Barts Hospital London, Head of Histopathology at CRUK and ex-president of the Pathological Society of Great Britain
MediSieve is a London biotech start-up developing Magnetic Haemofiltration, a revolutionary platform therapy that enables the physical removal of specific substances from the bloodstream of patients. It can be used (1) as a direct treatment, (2) to increase the safety and efficacy of other therapies, or (3) to enable personalised medicine. A unique, lifesaving and often cost-saving solution, there are several multi-billion-dollar markets available for this product in oncology, infectious diseases, auto-immune diseases, poisoning, drug overdose and others. Magnetic Haemofiltration has already been shown to rapidly, specifically, and effectively remove IL-6 from human plasma. The technology has completed pre-clinical validation, including animal studies, and is expected to start clinical studies in Q2 2022. MediSieve has raised £4M in equity funding and over £4M in non-dilutive grants. Seeking a further £8M at Series A to support pivotal clinical trials and regulatory approvals. EIS eligible. The company has been featured in numerous online and print media articles, including the Sunday Telegraph, Daily Mail, and Wired Magazine, and been winner or finalist in several start-up competitions such as Pitch@Palace, MassChallenge, OBN Awards, TCT Magazine Awards and CMS Healthcare Startup of the Year. Recently, our founder George Frodsham was awarded BBSRC Innovator of the Year and MIT Innovators Under 35.
AI-powered search designed for health professionals. Our mission is to empower every health professional to do their best work and provide better care for their patients
Neurofenix is an innovative digital therapeutics company empowering patients and their families to get their life back after suffering a stroke, traumatic brain injury or spinal cord injury. Our global team of highly motivated professionals includes bio-medical engineers, occupational therapists, software engineers and others. Many of us have personal experiences with neurological injuries, which inspire us in our day-to-day work. Neurofenix closed its Series A round of investment in August 2022, and is actively selling the NeuroBall platform to survivors, rehabilitation clinics and institutions for upper extremity recovery
MicrofluidX presents the Cyto Engine, a unified bioreactor and data platform for cell and gene therapy research, development, and manufacturing
The web platform and app to help women sync up with their moods, cycles and hormones. moodymonth.com
Cannaray Limited is a science-backed CBD and medical cannabis company. Cannaray was founded on the belief that when you fuse nature with innovative science, you can unleash the full power of cannabinoids. Cannaray CBD offers a range of premium CBD products for everyday wellbeing. Using a pure hemp extract at the heart of our products, Cannaray’s CBD blends are combined with quality natural ingredients to bring you the very best of CBD. From great-tasting CBD oils and gummies to vitamin-packed capsules and tingly topicals, our range is designed to fit seamlessly into your day to night routine. Cannaray’s products are triple lab tested for purity and suitable for vegans and vegetarians
